NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

NOXOPHARM LIMITED (NOX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of NOX: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Group
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000NOX9
Address: Level 5, 126 Phillip Street, Sydney, NSW 2000
Tel:  +61 2 91442223Fax: +61 2 91999600

Date first listed: 09/08/2016
Company Secretary: David Franks
Sector: Pharmaceuticals & Biotechnology 
Activities: Pharmaceuticals and Biotechnology

News & Events

Expand this box to read and print

The securities of Noxopharm Limited will be reinstated to quotation immediately, following the release of an announcement by the Company.

24/08/2017

The company announces the placement of 16,666,667 fully paid ordinary shares to sophisticated and institutional investors at a price of $0.33 per share, raising a total of A$5,500,000 (before costs). Noxopharm has raised the funds to enable it to accelerate the clinical development of its front-line drug, NOX66, currently undergoing clinical trialing.

24/08/2017

The securities of Noxopharm Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company.

23/08/2017

listed entity carried for record purposes only

09/08/2016

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    14/09/2023Fred Bart253,001$0.036$9,108
    30/06/2023Fred Bart135,281$0.042$5,682
    09/05/2023Fred Bart500,000$0.042$21,000
    04/05/2023Fred Bart1,000,000$0.050$50,000
    24/07/2020Fred Bart-3,056,318$0.344$1,051,068

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Fred BartNon Exec Chairman08/05/2020
    Peter MarksDeputy Chairman, Non Exec Director09/08/2016
    Gisela MautnerManaging Director, CEO01/02/2022
    Boris PatkinNon Exec Director26/03/2020

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Graham KellyNon Exec Director27/10/201520/09/2022
    Ian DixonNon Exec Director09/08/201631/08/2020
    Greg van WykCEO23/04/201928/10/2019
    Beata NiechodaNon Exec Director16/07/201916/10/2019
    John MooreNon Exec Director21/11/201816/07/2019
    Christopher CoxDirector09/08/201616/07/2019

    Date of first appointment, title may have changed.